Bioventix Valuation
| BVXP Stock | 2,775 75.00 2.63% |
At this time, the firm appears to be overvalued. Bioventix shows a prevailing Real Value of USD2454.9 per share. The current price of the firm is USD2775.0. Our model approximates the value of Bioventix from analyzing the firm fundamentals such as Current Valuation of 142.76 M, return on equity of 0.67, and Profit Margin of 0.60 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bioventix's price fluctuation is very steady at this time. Calculation of the real value of Bioventix is based on 3 months time horizon. Increasing Bioventix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioventix stock is determined by what a typical buyer is willing to pay for full or partial control of Bioventix. Since Bioventix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioventix Stock. However, Bioventix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2775.0 | Real 2454.9 | Hype 2775.0 | Naive 2736.54 |
The intrinsic value of Bioventix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioventix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bioventix helps investors to forecast how Bioventix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioventix more accurately as focusing exclusively on Bioventix's fundamentals will not take into account other important factors: Bioventix Total Value Analysis
Bioventix is currently projected to have takeover price of 142.76 M with market capitalization of 144.85 M, debt of 1.73 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bioventix fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
142.76 M | 144.85 M | 1.73 M |
Bioventix Investor Information
About 69.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 7th of November 2024. Based on the key measurements obtained from Bioventix's financial statements, Bioventix is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Bioventix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioventix has an asset utilization ratio of 99.09 percent. This implies that the Company is making USD0.99 for each dollar of assets. An increasing asset utilization means that Bioventix is more efficient with each dollar of assets it utilizes for everyday operations.Bioventix Ownership Allocation
The market capitalization of Bioventix is USD144.85 Million. Over half of Bioventix's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Bioventix. Please watch out for any change in the institutional holdings of Bioventix as this could mean something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Bioventix Profitability Analysis
The company reported the revenue of 13.61 M. Net Income was 8.1 M with profit before overhead, payroll, taxes, and interest of 12.68 M.Bioventix Past Distributions to stockholders
About Bioventix Valuation
The stock valuation mechanism determines Bioventix's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bioventix based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioventix. We calculate exposure to Bioventix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioventix's related companies.Additional Tools for Bioventix Stock Analysis
When running Bioventix's price analysis, check to measure Bioventix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventix is operating at the current time. Most of Bioventix's value examination focuses on studying past and present price action to predict the probability of Bioventix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventix's price. Additionally, you may evaluate how the addition of Bioventix to your portfolios can decrease your overall portfolio volatility.